Concerns on glucocorticoid use for Japanese patients with established rheumatoid arthritis
- PMID: 28830885
- DOI: 10.1136/annrheumdis-2017-212206
Concerns on glucocorticoid use for Japanese patients with established rheumatoid arthritis
Keywords: early rheumatoid arthritis; rheumatoid arthritis; treatment.
Conflict of interest statement
Competing interests: HO reports personal fees from Astellas, Ayumi, Daiichi, Sankyo, Eisai, Dainippon Sumitomo, Chugai Pharmaceutical, outside the submitted work. HO has received lecture fees from Mitsubishi Tanabe, Takeda, AbbVie, Chugai, BMS, Astellas, Ayumi, Daiichi-Sankyo, Eisai, Asahi Kasei and Dainippon Sumitomo.
Comment in
-
Response to: 'Concerns on glucocorticoid use for Japanese patients with established rheumatoid arthritis' by Oiwa.Ann Rheum Dis. 2018 Jul;77(7):e36. doi: 10.1136/annrheumdis-2017-212229. Epub 2017 Sep 28. Ann Rheum Dis. 2018. PMID: 28970206 No abstract available.
Comment on
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Ann Rheum Dis. 2017. PMID: 28264816 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical